Susannah Gray is of Theravance Biopharma, Inc.. Currently has a direct ownership of 42,137 shares of TBPH, which is worth approximately $449,601. The most recent transaction as insider was on May 19, 2025, when has been sold 10,649 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.1K
33.82% 3M change
33.82% 12M change
Total Value Held $449,601

SUSANNAH GRAY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2025
BUY
Grant, award, or other acquisition
-
10,649 Added 20.17%
42,137 Ordinary Shares
May 08 2024
BUY
Grant, award, or other acquisition
-
10,537 Added 25.07%
31,488 Ordinary Shares
May 02 2023
BUY
Grant, award, or other acquisition
-
9,132 Added 30.36%
20,951 Ordinary Shares
Feb 26 2023
BUY
Grant, award, or other acquisition
-
11,819 Added 50.0%
11,819 Ordinary Shares

Also insider at

MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC. Healthcare
MORF
Morphic Holding, Inc. Healthcare
FDMT
4D Molecular Therapeutics, Inc. Healthcare
APR
Apria, Inc. Healthcare
SG

Susannah Gray

San Diego, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH